1. Henson MC, Chedrese PJ. Endocrine disruption by cadmium, a common environmental toxicant with paradoxical effects on reproduction. Exp Biol Med (Maywood) 2004;229:383-392.
2. Kumar A, Scott Clark C. Lead loadings in household dust in Delhi, India. Indoor Air 2009;19:414-420.
3. Rosin A. The long-term consequences of exposure to lead. Isr Med Assoc J 2009;11:689-694.
4. Mercier M. International approach of the assessment of chemical risks. J Hyg Epidemiol Microbiol Immunol 1990;34:1-7.
6. Harada M. Minamata disease: methylmercury poisoning in Japan caused by environmental pollution. Crit Rev Toxicol 1995;25:1-24.
7. Vig EK, Hu H. Lead toxicity in older adults. J Am Geriatr Soc 2000;48:1501-1506.
8. Jomova K, Valko M. Advances in metal-induced oxidative stress and human disease. Toxicology 2011;283:65-87.
9. Engström A, Michaëlsson K, Vahter M, et al. Associations between dietary cadmium exposure and bone mineral density and risk of osteoporosis and fractures among women. Bone 2012;50:1372-1378.
10. Jin GB, Inoue S, Urano T, et al. Induction of anti-metallothionein antibody and mercury treatment decreases bone mineral density in mice. Toxicol Appl Pharmacol 2002;185:98-110.
12. Suzuki H, Asakawa A, Li JB, et al. Zinc as an appetite stimulator - the possible role of zinc in the progression of diseases such as cachexia and sarcopenia. Recent Pat Food Nutr Agric 2011;3:226-231.
13. Wallin M, Barregard L, Sallsten G, et al. Low-level cadmium exposure is associated with decreased bone mineral density and increased risk of incident fractures in elderly men: the MrOS Sweden study. J Bone Miner Res 2016;31:732-741.
14. Vanitallie TB. Frailty in the elderly: contributions of sarcopenia and visceral protein depletion. Metabolism 2003;52:22-26.
15. Lloyd BD, Williamson DA, Singh NA, et al. Recurrent and injurious falls in the year following hip fracture: a prospective study of incidence and risk factors from the Sarcopenia and Hip Fracture study. J Gerontol A Biol Sci Med Sci 2009;64:599-609.
17. Frisoli A Jr, Chaves PH, Ingham SJ, et al. Severe osteopenia and osteoporosis, sarcopenia, and frailty status in community-dwelling older women: results from the Womens Health and Aging Study (WHAS) II. Bone 2011;48:952-957.
18. Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 2014;15:95-101.
20. Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr 1997;127:990s-991s.
24. Alfvén T, Järup L, Elinder CG. Cadmium and lead in blood in relation to low bone mineral density and tubular proteinuria. Environ Health Perspect 2002;110:699-702.
26. Hamilton JD, O'Flaherty EJ. Effects of lead exposure on skeletal development in rats. Fundam Appl Toxicol 1994;22:594-604.
29. Potula V, Kleinbaum D, Kaye W. Lead exposure and spine bone mineral density. J Occup Environ Med 2006;48:556-564.
31. Ma Y, Fu D, Liu Z. Effect of lead on apoptosis in cultured rat primary osteoblasts. Toxicol Ind Health 2012;28:136-146.
33. Puzas JE, Sickel MJ, Felter ME. Osteoblasts and chondrocytes are important target cells for the toxic effects of lead. Neurotoxicology 1992;13:783-788.
35. Cho GJ, Park HT, Shin JH, et al. The relationship between blood mercury level and osteoporosis in postmenopausal women. Menopause 2012;19:576-581.
36. Chen X, Wang K, Wang Z, et al. Effects of lead and cadmium co-exposure on bone mineral density in a Chinese population. Bone 2014;63:76-80.